Background: Over the last couple of decades, there has been much discussion on how best to manage patients with recurrent traumatic anterior glenohumeral instability. When dealing with bone loss due to repeated shoulder dislocation, Latarjet and Eden Hybinette are both excellent treatment options. In instances of recurrent shoulder dislocation with glenoid bone loss or Hill Sachs lesion of the humeral head, the goal of this study is to evaluate the functional outcomes of Latarjet against free tricortical iliac graft.Cases and procedures: Forty adult patients with repeated shoulder dislocations and bone loss participated in this prospective randomised controlled trial (RCT). Two groups of patients were selected at random. (twenty cases of Eden Hybinette and twenty handles for Latarjet aircraft). We compared the outcomes radiographically using CT after at least six months and clinically using the modified Rowe score. Potential side effects in both groups were also recorded. No clinically or radiographically significant differences were seen between the groups (P >.05). Latarjet group had significantly reduced ROM (particularly internal and exterior rotation) at the last follow-up (P.05). Tramadol caused repeated dislocation in one patient in the latarjet group. Two people in each set had solely frontal lobe anxiety. Ten percent of patients in the Eden group had donor-site sensory problems. On CT, the grafts in the iliac group seemed bigger. In conclusion, Latarjet and Eden Hybinette are two competing methods for regaining bone-loss-related shoulder stability.better ROM.